P&G Health Q2 results: PAT dips 6% to Rs 72 crore; Firm announces interim dividend of Rs 200 per share
Total income for the period under review stood at Rs 315 crore as against Rs 314 crore in the year-ago period, Procter & Gamble Health said in a regulatory filing. The company follows a July-June financial year.
Procter & Gamble Health Ltd on Tuesday said its profit after tax declined 6 per cent to Rs 72 crore for the second quarter ended December 2023. The company had reported a Profit After Tax (PAT) of Rs 77 crore in the October-December period of the last fiscal.
Total income for the period under review stood at Rs 315 crore as against Rs 314 crore in the year-ago period, Procter & Gamble Health said in a regulatory filing. The company follows a July-June financial year.
"This has been a challenging quarter for the company on account of an overall slowdown in the vitamins, minerals and supplements category coupled with a delayed seasonal onset," P&G Health India MD Milind Thatte said.
With improved productivity, efficiency and continued strategic investments, the company has been able to deliver a modest topline and bottom line, he added. The company said its board has declared an interim dividend of Rs 200 per share for the financial year 2023-24.
Shares of the company settled 3.7 per cent higher at Rs 5,328.50 apiece on the BSE.
Catch the latest stock market updates here. For all other news related to business, politics, tech, sports, and auto, visit Zeebiz.com.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.